Fibroblast growth factor 21 as a candidate of a novel serum biomarker for mitochondrial diabetes.

Serum fibroblast growth factor 21 levels in patients with mitochondrial diabetes might be much higher than in those with other diabetes types. The results of this study could lead to the establishment of a simple method for screening mitochondrial diabetes using peripheral blood serum.